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Changes in urine composition after trauma
facilitate bacterial growth
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Odile Bouvet1, Eric Vicaut5, Erick Denamur1 and Jacques Duranteau2
Abstract
Background: Critically ill patients including trauma patients are at high risk of urinary tract infection (UTI). The
composition of urine in trauma patients may be modified due to inflammation, systemic stress, rhabdomyolysis, life
support treatment and/or urinary catheter insertion.
Methods: Prospective, single-centre, observational study conducted in patients with severe trauma and without a
history of UTIs or recent antibiotic treatment. The 24-hour urine samples were collected on the first and the fifth
days and the growth of Escherichia coli in urine from patients and healthy volunteers was compared. Biochemical
and hormonal modifications in urine that could potentially influence bacterial growth were explored.
Results: Growth of E. coli in urine from trauma patients was significantly higher on days 1 and 5 than in urine of
healthy volunteers. Several significant modifications of urine composition could explain these findings. On days 1
and 5, trauma patients had an increase in glycosuria, in urine iron concentration, and in the concentrations of
several amino acids compared to healthy volunteers. On day 1, the urinary osmotic pressure was significantly lower
than for healthy volunteers.
Conclusion: We showed that urine of trauma patients facilitated growth of E. coli when compared to urine from
healthy volunteers. This effect was present in the first 24 hours and until at least the fifth day after trauma. This
phenomenon may be involved in the pathophysiology of UTIs in trauma patients. Further studies are required to
define the exact causes of such modifications.
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Background
Urinary tract infections (UTIs) are the most common
infections acquired by hospitalized adult patients, with
an estimated prevalence as high as 10%. UTIs account
for up to 40% of hospital-acquired infections [1,2]. In
approximately 15% of cases of nosocomial bacteraemia,
the urinary tract is implicated as the portal of entry [1].
Several studies have reported that UTIs increase mor-
bidity, healthcare cost and length of hospital stay [3-5].
Asymptomatic bacteriuria is a common cause of in-
appropriate antibiotic prescription, which may play a
role in the emergence of resistant pathogens. Therefore,
it is important to reduce the rate of hospital-acquired
UTIs.
The occurrence of UTIs is increased in the presence
of indwelling urinary catheters, particularly over time.
Urinary catheterisation is a major identified risk factor
of urosepsis because its presence allows bacteria to col-
onise the urinary tract [6]. The other identified inde-
pendent risk factors for bacteriuria in the intensive care
unit (ICU) are gender (female), length of ICU stay, and
severity score at admission [7]. Many of the pathological
states of critically ill patients lead to relative immuno-
suppression, with impairment of the ability of neutro-
phils to kill bacteria [8]. The ability of urine from
seriously ill patients to support bacterial growth may
also play an important role in the occurrence of UTIs.
But, the role of urine composition in bacterial prolifera-
tion in critically ill patients has not been studied.
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In normal individuals, urine is limited in nutrients,
which are essential to bacterial growth, such as iron [9].
Urinary amino acids are important sources of carbon, ni-
trogen and sulphur, and play a key role in bacterial
defences against osmotic stress [9-11]. Urine compos-
ition in trauma patients can be modified by inflamma-
tion, systemic stress, rhabdomyolysis, the treatment
received for life support and possibly by the presence of
a urinary catheter. For example, endogenous or exogen-
ous catecholamines in urine could promote bacterial
growth and facilitate bacteriuria, leading to an increase
in susceptibility to infection [12].
The aim of this study was to determine if urine of
trauma patients facilitates bacterial proliferation com-
pared to urine of healthy volunteers and to describe
urine composition changes, which may promote bacter-
ial growth.
Methods
Patients
Adult trauma patients admitted to the 22-bed surgical
ICU from the university hospital of Bicêtre (AP-HP,
France) with an Injury Severity Score (ISS) [13] higher
than 16 and requiring an indwelling urethral catheter
were eligible for enrolment. Patients were not included
if (i) antibiotic therapy was predicted to be necessary for
clinical care when admitted to the ICU (except for
prophylactic antibiotics), (ii) hospitalization occurred be-
fore ICU admission, (iii) the expected duration of stay in
the ICU was shorter than 5 days, (iv) they were less than
18 years of age or pregnant, or (v) they had genitourin-
ary trauma. The ethics committee of the Lariboisière
Hospital (Paris, France) agreed to the protocol used in
this research. The informed written consent was deemed
non applicable as patient samples were taken as part of
standard care.
The demographic characteristics of each patient, in-
cluding age and gender, were recorded. The severity of
illness was assessed by Simplified Acute Physiology
Score (SAPS) II [14], Systemic Organ Failure Assessment
(SOFA) score [15], and ISS at admission to the ICU, and
(for the SOFA score) at five days. The following clinical
and laboratory variables were recorded at the time of
urine collection, at the first and the fifth days of ICU
hospitalisation: (i) interventions including antibiotic ad-
ministration from the first to the fifth day (antibiotic
used, dose and duration which allowed us to determine
whether antibiotics were given for prophylaxis or treat-
ment), invasive mechanical ventilation and catechol-
amine infusion; (ii) biochemical data including arterial
lactate (normal values: 0.5 to 2.2 mmol/L), plasma
pH (7.40 ± 0.2), 24-hour urine flow, serum creatinine
(normal values: 60 to 120 μmol/L), creatinine clearance
(normal values > 80 mL/min), blood urea (normal values:
4 to 7 mmol/L), plasma creatinine kinase level (normal
values < 250 U/L) ; (iii) and urinary bacteriology.
Urine samples
Sterile urine samples over 24 hours were collected with
an indwelling urinary catheter at day 1 (D1) and day 5
(D5) of the stay in the ICU. After centrifugation and fil-
tration (0.22 μm pore size), urine samples were stored at
−20°C.
Sterile urine from 6 healthy male volunteers (HV)
aged between 22 and 50 years old [median of 28 years,
(IQR, 25.5, 32.5)] with no history of UTIs or antibiotic
use during the previous two months was collected. Fur-
thermore, HV were free of iron intake. Before being
stored at 4°C if used in the following 48 hours, or at
– 20°C, midstream urine from at least three of the six
HV were pooled. Twelve urine batches were studied.
Urinary biochemical assays
The volume, biochemistry sodium (normal values: 50 to
200 mmol/24 hours), potassium (normal values: 50
to 150 mmol/24 hours), urea (normal values: 200 to
500 mmol/24 hours) and creatinine (normal values: 9
to 16 mmol/24 hours), pH (normal values: 5 to 7),
osmolality (normal values: 700 to 1000 mosm/L, glucose,
protein (normal values < 0.1 g/24 hours) and urinary
sediment were recorded for each urine sample. Urinary
glucose concentration higher than 0 mmol/l was consi-
dered as abnormal, based on the pathology lab‘s defi-
nition. The concentration of free iron was measured by
spectrophotometry on a Modular PP analyser (Fer/
RocheW; Roche Diagnostic) in urine of patients and HV.
Urine samples were firstly acidified to a pH <2 to sepa-
rate iron from carrier proteins. As described previously
[16], ascorbate was added to allow the reduction of Fe3+.
Then, FerroZine was used to determine the free iron
concentration.
The urinary concentrations of nitrates were measured
as described previously [17]. The levels of amino acids
were determined using High Performance Level Chro-
matography (HPLC) on 24 samples (9 from urine of HV,
15 from 8 patients (8 samples collected on day 1, and 7
on day 5) [18]. The concentrations of norepinephrine,
dopamine and epinephrine, which are known to influ-
ence bacterial growth, were measured on 24 samples
from patients (12 samples collected on day 1 and 12 col-
lected on day 5). Catecholamines were extracted from
urine by ion exchange chromatography followed by alu-
mina adsorption. Extracted catecholamines were sepa-
rated and quantified by an HPLC method with
amperometric detection [19,20]. This method is specific
for catecholamines and does not detect oxidized deriva-
tives such as o-quinone or adrenochrome. The concen-
trations of urinary catecholamines of trauma patients
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were compared with reference values measured in a
healthy population (dopamine < 630 μg/g of creatinine,
epinephrine <16 μg/g of creatinine and norepinephrine
< 77μg/g of creatinine) [19].
Bacterial strains
Two strains of E. coli were studied. E. coli CFT073, the
prototype of the uropathogenic (UPEC) strains, was ori-
ginally isolated from the blood and urine of a woman
admitted to the University of Maryland Medical System
(USA) [21]. E. coli CFT073 is fully sensitive to antibio-
tics. The second strain is E. coli R1B8J20 isolated during
a septicaemia recorded in the prospective COLIBAFI
study [22]. E. coli R1B8J20 is resistant to beta-lactams
due to over-production of AmpC cephalosporinase. The
minimal inhibitory concentrations for the following anti-
biotics, determined using an E-test method, were: cefta-
zidime >256 mg/L, cefoxitin >192 mg/L, cefepime =
16 mg/L, cefotaxime = 12 mg/L, amoxicillin-clavulanic
acid >256 mg/L. This strain was also resistant to quino-
lones, kanamycin, streptomycin and sulfonamides. E. coli
R1B8J20 allowed an evaluation of bacterial growth in
urine of patients who had received antibiotics.
Bacterial growth assays
Both E. coli strains were cultured in 4 ml of Luria
Bertani medium for 18 hours at 37°C. The overnight cul-
tures were centrifuged (4500 rpm during 15 min) and
washed with 4 ml of isotonic saline serum. Forty ml of
urine were inoculated with the volume of the overnight
culture required to obtain a starting optical density of
0.01 at 600 nm (OD600), which corresponded to 2×10
6
bacteria/mL, and incubated at 37°C with an agitation at
180 rpm. Optical density was measured at intervals with
an Ultrospec 1100 pro (PharmaciaW) spectrophotometer,
until the culture reached stationary phase or at least
over 420 minutes.
Experiments were normally carried out using E. coli
CFT073. When the patient received prophylactic anti-
biotics or therapeutic antibiotic therapy before the fifth
day that was not predicted at admission, the resistant
E. coli R1B8J20 isolate was also studied. Experiments
were done in replicates.
To study the role of iron in bacterial proliferation, E. coli
CFT073 growth in urine from trauma patients was studied
after addition of an iron chelator, desferrioxamine
(0.1 mM), using three urine samples collected on the first
day from patients who were not on antibiotics. The inhibi-
tory effect of desferrioxamine was expressed by percentage
of growth inhibition after 360 minutes of growth.
The effect of norepinephrine was studied after
addition of 1 μM, 10 μM or 50 μM to HV urine samples,
using the method described by Freestone et al. [23].
These experiments were carried out using two inde-
pendent HV urine samples.
Statistical Analysis
The clinical and biological characteristics recorded on
days 1 and 5 were compared using the Student t test
(MedCalc). The biochemical characteristics of urine
from trauma patients on days 1 and 5 were compared
with the biochemical characteristics of urine from HV.
When statistical distribution was Gaussian, mean differ-
ence in means and 95% confidence interval (CI) are
shown. In cases of non Gaussian statistical distribution,
the median difference and non parametric Hodges-
Lehman 95% CI are shown. The growth of E. coli
CFT073 in urine from patients without antibiotics on
day 1 was compared with E. coli CFT073 growth in HV
urine, using an analysis of variance for repeated mea-
sures (Statview). The same analysis was carried out for
urine collected on day 5, and for the resistant strain E.
coli R1B8J20. Finally, growth in urines from the first and
the fifth days was compared. Spearman’s nonparametric
correlation coefficient was used to correlate clinical or
biological parameters and growth (Statview). The results
are expressed in mean ± standard deviations. Statistical
significance was fixed at 0.05 (two-tailed).
Results
Patients and urine samples
Twenty-two patients with severe trauma were recruited
to the study over a period of 11 months.
Of these 22 patients, sixteen received prophylactic
antibiotics on day 1, and one had a positive bacterio-
logical urine culture (Proteus mirabilis 105/mL)
(Figure 1). On day 5, two patients had received antibio-
tics from day 2 for a hospital-acquired infection, three
patients had positive bacteriological samples (>105/mL
of P. mirabilis, coagulase-negative Staphylococcus,
Enterococcus faecalis) and 4 of 22 samples were not
available because the indwelling catheter was removed
before day 5 (Figure 1).
The demographic and clinical characteristics are sum-
marized in Table 1. On day 5, the majority of patients
showed signs of recovery, demonstrated by a decrease in
the SOFA score and the number of patients requiring
life support. The significant improvement in biological
parameters such as the creatinine clearance and the
serum lactate level also demonstrated this trend
(Table 2).
Bacterial growth assays
On day 1, for urine from five patients who were not
treated with an antibiotic, the growth of the susceptible
strain, E. coli CFT073, was statistically higher than in
HV urine (p = 0.0028) (Figure 2). For the 16 patients
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who received prophylactic antibiotics on day 1, the
growth of E. coli R1B8J20, the resistant strain, was stud-
ied in 5 urine samples. Growth was inhibited in 1 sam-
ple. The 4 remaining urine samples supported a
significantly better growth than HV urine (p = 0.0371)
(Figure 3). When tested in HV urine or in TP urine,
there was no difference in growth between the two
strains (data not shown).
Growth of E. coli CFT073 was evaluated for the 13
urine samples from patients without bacteriuria and
without antibiotic on day 5. The growth in these 13
samples was statistically greater than in HV urine (p =
0.0108) (Figure 4). Results similar to the E. coli CFT073
strain were found for E. coli R1B8J20 grown in the 8
tested samples from the 13 patients without antibiotics
and compared to HV urine growth (p = 0.0478). One of
the 2 patients with antibiotics on day 5 had received
gentamicin; as both strains of E. coli were susceptible to
this antibiotic, only the sample from the patient who did
not received gentamicin was evaluated. The bacterial
growth was higher than in HV urine (data not shown).
To test the role of iron in the bacterial growth,
we carried out inhibition experiments using an iron che-
lator in urine from 3 patients who did not received anti-
biotics at day 1. Addition of desferrioxamine (0.1 mM)
in trauma urine suppressed growth, with a decrease in
the number of bacteria at the stationary phase of around
40% (± 20%).
Figure 1 Study design. Twenty-two patients were included. Urine was collected on the first and fifth day after trauma to evaluate bacterial
growth.
Table 1 Demographic and clinical characteristics of the
22 trauma patients on day 1 and on day 5 after the onset
of trauma
Variables D1 D5
Ages, years (mean ± SD) 35 ± 14
Male, n (%) 15 (68%)
ISS (mean ± SD) 30 ± 12
SAPS II (mean ± SD) 33 ± 16
SOFA score (mean ± SD) 6 ± 3 3 ± 4
Patients with invasive MV, n (%) 16 (73%) 11 (50%)
Patients with catecholamines, n (%) 16 (73%) 5 (23%)
Patients with antibiotics, n (%) 16 (73%) 2 (9%)
Urine output, mL/24h (mean ± SD) 1800 ± 890 2500 ± 1000
MV Mechanical ventilation, ISS Injury Severity Score, SAPS II Simplified Acute
Physiology Score, SOFA Systemic Organ Failure Assessment, D1 on day 1, D5
on day 5.
Table 2 Biological characteristics of the 22 trauma
patients on day 1 and on day 5 after the onset of trauma
Variables D1 D5 P
Plasma pH 7.32 ± 0.07 7.40 ± 0.05 0.0001
Lactatemia (mmol/L) 1.9 ± 1.3 1.0 ± 0.4 0.005
Creatinine clearance (mL/min) 112 ± 55 191 ± 101 0.0025
Uremia (mmol/L) 4.9 ± 1.8 4.9 ± 2.3 ns
Creatininaemia (μmol/L) 76 ± 36 58 ± 20 0.0466
Bacteriuria, n (%) 1 (4.5%) 3 (14%) ns
D1 on day 1, D5 on day 5.
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The addition of norepinephrine (1 μM, 10 μM and
50 μM) to HV urine does not change E. coli CFT073
strain proliferation in our experimental conditions (data
not shown).
Urinary biochemical assays
On day 1, the levels of urea and creatinine, and the urin-
ary osmolarity, were significantly lower in the urine of
trauma patients (TP urine) than in HV urine (Table 3).
Moreover, all of the patients had a glycosuria, and 80%
of them had subnormal levels of urinary iron (Table 4).
Seventy-seven per cent of the patients had received a
norepinephrine infusion on day 1. The urinary norepin-
ephrine concentration was above normal values in 75%
of patients receiving norepinephrine on day 1 and in
40% of patients who had not received catecholamines
(Table 4).
On day 5, glycosuria was present in all patients, and
proteinuria was higher in TP urine than in HV urine.
There was no difference in urinary osmolarity, and urin-
ary iron and urea concentrations between TP and HV
urines (Tables 4 and 5). Less than 45% of the patients
had a urinary concentration of norepinephrine above
normal values (Table 4), and three fourth of them still
received catecholamines.
Analysis of amino acids revealed an increase of urinary
excretion of glutamic acid, valine, methionine, leucine,
tyrosine, histidine and phenylalanine during the first 24
hours after trauma (Table 6). By the fifth day post-
trauma, the excretion of almost all amino acids had sig-
nificantly increased (Table 7).
Discussion
UTIs are one of the most important hospital-acquired
infections in ICUs and are responsible for a large
Figure 2 Comparison of the growth of E. coli CFT073 in urine, collected on day 1, from trauma patients not receiving antibiotic (n = 5)
(dashed line), and from healthy volunteers (n = 12) (complete line) (p = 0.0028).
Figure 3 Comparison of the growth of E. coli R1B8J20 in urine, collected on day 1, from trauma patients receiving prophylactic
antibiotics (n = 4) (dashed line), and from healthy volunteers (n = 7) (complete line) (p = 0.0371).
Aubron et al. BMC Infectious Diseases 2012, 12:330 Page 5 of 10
http://www.biomedcentral.com/1471-2334/12/330
proportion of antibiotics prescribed. Few of the known
risk factors are preventable, making it important to im-
prove our understanding of the underlying causes of
UTIs. In our study we have demonstrated that urine of
severe trauma patients favours the growth of E. coli,
which is the most frequently isolated species in UTIs
[7,25]. This effect is present during the first 24 hours,
and remains at least until the fifth day after occurrence
of trauma.
The changes in urinary composition induced not only
by shock and trauma, but also by the urinary catheter
could facilitate bacterial growth of both susceptible and
resistant strains. Comparing the urine from trauma
patients with that from healthy volunteers highlights a
significant increase in glycosuria, urinary amino acids,
urinary iron and norepinephrine concentrations, and a
significant decrease in urinary urea concentrations and
osmotic pressure. These could, together, play a role in
the difference seen in bacterial growth. When norepin-
ephrine was added to HV urine this alone did not facili-
tate bacterial growth.
Critically ill patients are often characterized by insulin
resistance associated with impaired glucose tolerance
and hyperglycemia. This stress induced-hyperglycemia
leads to glycosuria, which is known to support bacterial
growth in urine [26,27].
The changes in urinary amino acids concentration that
we have shown are also well known to influence growth
of E. coli in urine [9,11,28]. Bacterial growth in urine is
dependent on the availability of nitrogen. Some amino
acids, such as serine or glutamic acid, increase E. coli
growth [29,30] (personal data). In critically ill patients,
anabolic resistance and increased energy requirements
lead to proteolysis, with a corresponding increase in the
efflux of amino acids. Systemic inflammation alters
amino acid transport through muscle cells. The increase
in plasma amino acids levels could lead to a rise in urin-
ary excretion [31-33]. In agreement with the work of
Freund et al., we found that sulphur- containing amino
acid (methionine), aromatic amino acids (phenylalanine
and tyrosine) and branched chain amino acids (leucine
and valine) are excreted early [34]. Then, at the fifth day
Figure 4 Comparison of the growth of E. coli CFT073 in urine from trauma patients not receiving antibiotic collected on day 5 (n = 13)
(dashed line), and from healthy volunteers (n = 12) (complete line) (p = 0.0108).
Table 3 Comparison of biochemical characteristics between urine from trauma patients on day 1 (D1) and from
healthy volunteers (HV)
Variables Values D1 Values HV HV-D1 mean or median differences [CI95%]
Urea (mmol/L) 134 ± 76 296 ± 59 162 [104; 220]
Creatinine (μmol/L) 6.31 ± 4.04 10.55 ± 3.29 4.25 [1.14; 7.36]
Sodium (mmol/L) 80 ± 44 104 ± 43 29.28 [−7.09; 65.65]
Potassium (mmol/L) 44 ± 28 51 ± 20 9.83 [−11.44; 31.11]
Proteinuria (g/L) 0.57 ± 0.67 0.017 ± 0.025 −0.55 [ −1.11; 0.01]
pH 6.08 ± 1.02 6.7 ± 0.32 0.60 [−0.04; 1.25]
Osmolality (mosmol/L) 273 ±129 515 ± 92 241.76 [160.66; 322.86]
Nitrates (nmol/mg of protein) 34 ± 57 63 ± 45 31.25 [10.55; 51.95] a
D1 on day 1.
a Medians difference and Hodges-Lehmann 95% Confidence Interval.
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we showed an increase in the levels of excretion of the
majority of amino acids as the result of catabolism, as
well as renal damage in some cases. The urine iron level
in healthy individuals is usually too low to support bac-
terial growth [9]. The occurrence of phenomena such as
rhabdomyolysis, blood transfusion or urinary tract
trauma and also urinary catheter insertion could explain
the higher iron levels. In our study, more than 80% of
trauma patients had rhabdomyolysis, which leads to
leakage of muscle proteins containing ferrous iron [35].
Half of the patients were transfused during the first five
days of their hospitalization, usually on the first day,
with a mean of 3.4 units per patient. Blood transfusion
can lead to intravascular haemolysis and haemoglobin-
uria. The role of iron in stimulating bacterial growth is
confirmed by our data showing growth inhibition after
addition of desferrioxamine, an iron chelator.
Some pathophysiological changes occurring in trauma
patients could lead to increased E. coli growth in urine
by a non-nutritional effect. There is a lower urea con-
centration in urine from trauma patients on day 1, in
comparison with HV urine, which could be explained by
the decrease in protein input and hypovolemia. Urea has
an antibacterial effect, which is independent of osmotic
pressure, but can also influence bacterial proliferation
through osmotic pressure [9,36].
The potential role of urinary catecholamines could be
explained by their inhibitory effect on bactericidal activ-
ity of leukocytes [37] and by their own effect on bacterial
multiplication [23,38,39]. Several studies have reported
that catecholamines stimulate bacterial proliferation.
However, these studies focused on gut flora and did not
explore bacterial growth in the urinary tract. With low
bacterial inoculum and during prolonged bacterial
growth, Freestone et al. have shown a positive effect of
norepinephrine on bacterial growth even at 1 μM, the
mean concentration of norepinephrine in the TP urine
[23]. We could not demonstrate under our experimental
conditions a positive and independent effect of norepin-
ephrine on bacterial growth, suggesting that the effect of
catecholamine alone is weak and requires the presence
of iron to stimulate bacterial multiplication.
Finally, in 5 cases bacteria were present in the urine;
they were in two cases P. mirabilis. These findings high-
light the predisposition of trauma patients to develop
asymptomatic bacteriuria.
Strengths of our study include i) its originality with
a new concept which could contribute to high
Table 4 Urinary concentrations of catecholamines, iron and glucose for patients at day 1 and day 5 and percentages of
patients with concentrations above the normal
Variables D1 D5
Values (means ± SD); % above the normal
[CI 95%]
Values (means ± SD); % above the normal [CI95%]
Dopamine > 630 (μg/g creatinine) 158 ± 53 ; 0.0 [0.00 ; 28.49] 154 ± 74 ; 0.0 [0.00; 28.49]
Epinephrine > 16 (μg/g creatinine) 15.3 ± 11.7; 50.0 [21.09; 78.91] 14.2 ± 10 ; 36.4 [10.93; 69.21]
Norepinephrine > 77 (μg/g creatinine) 219 ± 223 ; 69.2 [38.57; 90.91] 153 ± 195 ; 45.5 [16.75; 76.62]
Iron (μmol/L) > 0 0.65 ±1.02 ; 81.3 [54.35; 95.95] 0.24 ± 0.55 ; 41.2 [18.44; 67.08]
Glucose (g/L) > 0 1.45 ± 1.14 ; 100.0 [79.41; 100.00] 0.78 ± 0.61 ; 100.0 [80.49; 100.00]
D1 on day 1, D5 on day 5.
Table 5 Comparison of biochemical characteristics between urine from trauma patients on day 5 and from healthy
volunteers
Variables Values D5 Values HV HV-D5 mean or median differences [CI95%]
Urea (mmol/L) 225 ± 149 296 ± 59 83 [14; 179] a
Creatinine (μmol/L) 7.15 ± 4.45 10.55 ± 3.29 3.41 [0.02; 6.79]
Sodium (mmol/L) 95 ± 46 104 ± 43 13.30 [−24.42; 51.02]
Potassium (mmol/L) 36 ± 24 51 ± 20 20.45 [2.60; 38.30] a
Proteinuria (g/L) 0.34 ± 0.31 0.017 ± 0.025 −0.32 [−0.55; -0.09]
pH 7.35 ± 0.83 6.7 ± 0.32 −0.67 [−1.30; -0.04]
Osmolality (mosmol/L) 418 ± 180 515 ± 92 99.75 [−29.00; 228.50] a
Nitrates (nmol/mg of protein) 56 ± 46 63 ± 45 9.83 [−32.87 ; 52.52]
Values are expressed as means ± SD, D5 on day 5, HV healthy volunteers.
a Medians difference and Hodges-Lehmann 95% Confidence Interval.
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sensitivity of critically ill patients to infections; ii) the
exploration of nutritional and non-nutritional way to
facilitate bacterial growth; ii) the comparison between
patients and healthy volunteers. However, our study
has several limitations The list of metabolites that we
studied is not exhaustive; for example, we did not
explore interleukin (IL) urinary excretion, even
though IL-1 is known to be excreted during acute
kidney injury due to shock and is known to enhance
E. coli growth [24,40]. Eighteen patients received anti-
biotics at one stage of the study, making non inter-
pretable some urine samples. The fact that the
healthy volunteers did not have an indwelling bladder
catheter may be a confounding factor, because the
urinary catheter could change the urinary sediment or
cause cellular damage. If further investigations are
required to discriminate the potential role played by
the urinary catheter, the trauma and shock remain
the main cause of the increase in glycosuria, in amino
acid excretion and in change in urea concentration.
Conclusions
This study demonstrates that urine of trauma patients
supports E. coli growth better than urine from healthy
volunteers. This effect is present from the first 24 hours
and remains at least until the fifth day after trauma. The
effect is observed with antibiotic-resistant strains for
patients who have received antibiotics, highlighting the
impact of antibiotics on selection of resistant strains.
The changes in urinary glucose, amino acid and iron
concentrations, and urinary urea and osmotic pressure
could all play a part in the observed increase in E. coli
proliferation. This increase in the growth ability of E.
coli strains in urine of trauma patients could be one of
the elements facilitating UTIs in these patients. A better
understanding of the occurrence of bacteriuria is needed
to define interventions that could decrease the incidence
of UTIs in the context of the intensive care unit.
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Table 6 Comparison of urinary amino acid concentrations
between trauma patients on day 1 and healthy
volunteers
Amino acids D1 HV HV-D1 mean or median
differences [CI95%]
(μmol/L) Mean ± SD Mean ± SD
Taurine 738 ± 551 944 ± 597 205.98 [-390.38; 802.35]
Aspartic acid 14 ± 23 8 ± 2 -6.43 [-22.53; 9.66]
Threonine a 339 ± 519 105 ± 23 -233.38 [-601.06; 134.31]
Serine a 525 ± 596 242 ± 42 -283.04 [-686.74; 120.66]
Asparagine a 258 ± 329 72 ± 17 -186.31 [-419.08; 46.47]
Glutamic acid 83 ± 133 10 ± 7 -34.29 [-56.20; -12.37] b
Glutamine a 650 ± 608 326 ± 76 -323.98 [-757.79; 109.83]
Glycine a 1991 ± 2396 879 ± 211 -1111.23 [-2813.86; 591.41]
Alanine a 407 ± 273 240 ± 56 -167.22 [-365.07; 30.64]
Citrulline 74 ± 149 15 ± 5 -59.03 [-164.57; 46.51]
Valine 96 ± 69 36 ± 9 -60.71 [-109.93; -11.48]
Cystine 205 ± 337 35 ± 9 -73.56 [-145.20; -1.92] b
Methionine a 15 ± 11 5 ± 6 -10.23 [-19.00; -1.46]
Isoleucine 26 ± 13 17 ± 4 -9.02 [-19.04; 1.00]
Leucine 61 ± 49 18 ± 3 -43.30 [-77.81; -8.79]
Tyrosine 213 ± 167 76 ± 30 -137.20 [-257.38; -17.03]
Phenylalanine 433 ± 360 55 ± 10 -378.06 [-632.89; -123.23]
Ornithine 135 ± 339 7 ± 2 -13.81 [-26.96; -0.67] b
Histidine 1469 ± 1347 543 ± 159 -768.69 [-1447.56; -89.82] b
Lysine 2000 ± 5164 104 -1896.22 [-5550.61; 1758.18]
Arginine 71 ±147 11 ± 95 -85.12 [-238.12; 67.88]
D1 on day 1, HV healthy volunteers.
a Amino acids known to be particularly important during growth in urine for
E. coli (personal data and [11,17,18,24].
b Medians difference and Hodges-Lehmann 95% Confidence Interval.
Table 7 Comparison of urinary amino acid concentrations
between polytrauma patients on day 5 and healthy
volunteers
Amino acids D5 HV HV-D5 mean or median
differences [CI95%]
(μmol/lL) Mean ± SD Mean ± SD
Taurine 324 ± 301 944 ± 597 619.36 [87.15; 1151.57]
Aspartic acid 12 ± 15 8 ± 2 -4.45 [-14.94; 6.03]
Threonine a 778 ± 382 105 ± 23 -672.79 [-944.09; -401.49]
Serine a 841 ± 429 242 ± 42 -598.42 [-903.86; -292.97]
Asparagine a 459 ± 240 72 ± 17 -387.51 [-557.85; -217.18]
Glutamic acid 57 ± 49 10 ± 7 -46.82 [-81.78; -11.85]
Glutamine a 864 ± 365 326 ± 76 -538.03 [-803.53; -272.53]
Glycine a 2049 ± 985 879 ± 211 -1170.10 [-1888.18; -452.03]
Alanine a 390 ± 202 240 ± 56 -123.41 [-268.06; 21.25] b
Citrulline 73 ± 57 15 ± 5 -58.67 [-98.89; -18.44]
Valine 79 ± 46 36 ± 9 -43.29 [-76.66; -9.91]
Cystine 225 ± 209 35 ± 9 -189.76 [-337.97; -41.56]
Methionine a 9 ± 8 5 ± 6 -4.23 [-11.74; 3.28]
Isoleucine 22 ± 16 17 ± 4 -5.13 [-17.04; 6.78]
Leucine 52 ± 32 18 ± 3 -34.34 [-57.07; -11.61]
Tyrosine 222 ± 134 76 ± 30 -146.75 [-244.35; -49.16]
Phenylalanine 258 ± 187 55 ± 10 -202.73 [-334.94; -70.51]
Ornithine 99 ± 132 7 ± 2 -93.38 [-173.72; -13.05] b
Histidine 1267 ± 575 543 ± 159 -724.23 [-1151.22; -297.24]
Lysine 1542 ± 1993 104 -1437.41 [-2849.66; -25.15]
Arginine 54 ± 64 11 ± 95 29.48 [-86.49; 145.45]
D5 on day 5, HV healthy volunteers.
a Amino acids known to be particularly important during growth in urine for
E. coli (personal data and [11,17,18,24].
b Medians difference and Hodges-Lehmann 95% Confidence Interval.
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